DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants

NCT02817451 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Diphtheria
Tetanus
Pertussis
Hepatitis B
Polio
Human Immunodeficiency Virus Infection

Interventions

BIOLOGICAL: Hexaxim®: DTaP-IPV-HB-PRP-T Combined Vaccine
BIOLOGICAL: Hexaxim®: DTaP-IPV-HB-PRP-T Combined Vaccine

Sponsor

Sanofi Pasteur, a Sanofi Company